⌘K

Login Start Free

Home/Filings/4/0001144204-18-007442

4//SEC Filing

Cross Stefan 4

Accession 0001144204-18-007442

CIK 0001042418other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 8:00 PM ET

Size

4.8 KB

Accession

0001144204-18-007442

Insider Transaction Report

Form 4

Period: 2017-12-19

HedgePath Pharmaceuticals, Inc.HPPI

Director

Transactions

Purchase
Common Stock
2017-12-19$162660.00/sh−600,000$97,596,000,000→ 0 total

Footnotes (1)

[F1]On December 19, 2017, Stefan Cross sold 600,000 shares of Common Stock to Mayne Pharma Ventures Pty Ltd.

Documents

1 file

4
tv485758_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

HedgePath Pharmaceuticals, Inc.

CIK 0001042418

Entity typeother

Related Parties

1

filerCIK 0001611506

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 8:00 PM ET
Size: 4.8 KB

View on SEC.gov